Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Sep'24
Sep'23
Sep'22
Sep'21
Sep'20
Sep'19
Half Yearly Analysis Highlights
Net Sales
Growth in half year ended Sep 2025 is 16.04% vs 24.33% in Sep 2024
Standalone Net Profit
Growth in half year ended Sep 2025 is 29.44% vs 17.12% in Sep 2024
Operating Profit (PBDIT) excl Other Income
Growth in half year ended Sep 2025 is 25.97% vs 33.65% in Sep 2024
Interest
Growth in half year ended Sep 2025 is 17.76% vs 102.42% in Sep 2024
Operating Profit Margin (Excl OI)
Growth in half year ended Sep 2025 has improved from Sep 2024
Compare Half Yearly Results Of Dr Agarwal's Eye With
Figures in Cr
Standalone Half Yearly Results
Change(INR)
Change(%)
Net Sales
234.64
519.58
-284.94
-54.84%
Other Operating Income
0.00
0.00
0.00
Total Operating income
234.64
519.58
-284.94
-54.84%
Raw Material Cost
0.00
0.00
0.00
Purchase of Finished goods
23.72
0.00
23.72
(Increase) / Decrease In Stocks
0.45
0.00
0.45
Employee Cost
43.62
75.56
-31.94
-42.27%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
56.85
317.30
-260.45
-82.08%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
32.79
35.68
-2.89
-8.10%
Total Expenditure (Excl Depreciation)
157.43
428.54
-271.11
-63.26%
Operating Profit (PBDIT) excl Other Income
77.21
91.04
-13.83
-15.19%
Other Income
1.48
14.74
-13.26
-89.96%
Operating Profit (PBDIT)
78.69
105.78
-27.09
-25.61%
Interest
7.89
14.04
-6.15
-43.80%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
70.80
91.74
-20.94
-22.83%
Depreciation
21.89
21.90
-0.01
-0.05%
Profit Before Tax
48.91
69.84
-20.93
-29.97%
Tax
12.33
18.45
-6.12
-33.17%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
36.58
51.38
-14.80
-28.80%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
36.58
51.38
-14.80
-28.80%
Equity Capital
4.83
13.89
-9.06
-65.23%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
75.73
3.70
72.03
1,946.76%
Diluted Earnings per share
77.77
3.25
74.52
2,292.92%
Operating Profit Margin (Excl OI)
32.91%
17.52%
0.00
15.39%
Gross Profit Margin
30.17%
17.66%
0.00
12.51%
PAT Margin
15.59%
9.89%
0.00
5.70%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 234.64 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 16.04% vs 24.33% in Sep 2024
Half Yearly - Standalone Net Profit
Standalone Net Profit 36.58 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 29.44% vs 17.12% in Sep 2024
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 77.21 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 25.97% vs 33.65% in Sep 2024
Half Yearly - Interest
Interest 7.89 Cr
in Sep 2025Figures in Cr
Growth in half year ended Sep 2025 is 17.76% vs 102.42% in Sep 2024
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 32.91%
in Sep 2025Figures in %
Growth in half year ended Sep 2025 has improved from Sep 2024






